Jones Financial Companies
EBS icon

Jones Financial Companies’s Emergent Biosolutions EBS Stock Holding History

Jones Financial Companies’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.15K Hold
1,028
– – ﹤0.01% 3651
2025
Q4 		$12.7K Hold
1,028
– – ﹤0.01% 3122
2025
Q3 		$9.16K Buy
1,028
+93
+10% +$723 ﹤0.01% 3115
2025
Q2 		$5.94K Buy
935
+520
+125% +$2.98K ﹤0.01% 3080
2025
Q1 		$1.93K Buy
415
+15
+4% +$124 ﹤0.01% 3249
2024
Q4 		$3.82K Hold
400
– – ﹤0.01% 2832
2024
Q3 		$3K Hold
400
– – ﹤0.01% 2578
2024
Q2 		$2.73K Buy
+400
New +$1.72K ﹤0.01% 2090

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Jones Financial Companies's EBS Position: Q1 2026 in Review

Jones Financial Companies held its Emergent Biosolutions (EBS) position steady in Q1 2026 at 1,028 shares worth $8.15K. The position accounts for ﹤0.01% of the portfolio, ranked #3651.

Jones Financial Companies first reported a position in EBS in Q2 2024 and has held it in 8 quarters since. The position peaked at $12.7K in Q4 2025. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.

  • Jones Financial Companies held 1,028 shares of Emergent Biosolutions worth $8.15K as of Q1 2026.
  • Jones Financial Companies left its Emergent Biosolutions share count unchanged in Q1 2026.
  • Emergent Biosolutions made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #3651 holding.
  • Jones Financial Companies first reported a position in Emergent Biosolutions in Q2 2024 and has held it in 8 quarters since.
  • Jones Financial Companies's Emergent Biosolutions position peaked at $12.7K in Q4 2025.
  • 190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.